Skip to main content

Pharmacologic management of perioperative pulmonary hypertension.

Publication ,  Journal Article
Cheng, JW; Tonelli, AR; Pettersson, G; Krasuski, RA
Published in: J Cardiovasc Pharmacol
April 2014

Perioperative pulmonary hypertension can originate from an established disease or acutely develop within the surgical setting. Patients with increased pulmonary vascular resistance are consequently at greater risk for complications. Despite the various specific therapies available, the ideal therapeutic approach in this patient population is not currently clear. This article describes the basic principles of perioperative pulmonary hypertension and reviews the different classes of agents used to promote pulmonary vasodilation in the surgical setting.

Duke Scholars

Published In

J Cardiovasc Pharmacol

DOI

EISSN

1533-4023

Publication Date

April 2014

Volume

63

Issue

4

Start / End Page

375 / 384

Location

United States

Related Subject Headings

  • Vasodilator Agents
  • Perioperative Care
  • Hypertension, Pulmonary
  • Humans
  • Cardiovascular System & Hematology
  • 3214 Pharmacology and pharmaceutical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cheng, J. W., Tonelli, A. R., Pettersson, G., & Krasuski, R. A. (2014). Pharmacologic management of perioperative pulmonary hypertension. J Cardiovasc Pharmacol, 63(4), 375–384. https://doi.org/10.1097/FJC.0000000000000050
Cheng, Julie W., Adriano R. Tonelli, Gosta Pettersson, and Richard A. Krasuski. “Pharmacologic management of perioperative pulmonary hypertension.J Cardiovasc Pharmacol 63, no. 4 (April 2014): 375–84. https://doi.org/10.1097/FJC.0000000000000050.
Cheng JW, Tonelli AR, Pettersson G, Krasuski RA. Pharmacologic management of perioperative pulmonary hypertension. J Cardiovasc Pharmacol. 2014 Apr;63(4):375–84.
Cheng, Julie W., et al. “Pharmacologic management of perioperative pulmonary hypertension.J Cardiovasc Pharmacol, vol. 63, no. 4, Apr. 2014, pp. 375–84. Pubmed, doi:10.1097/FJC.0000000000000050.
Cheng JW, Tonelli AR, Pettersson G, Krasuski RA. Pharmacologic management of perioperative pulmonary hypertension. J Cardiovasc Pharmacol. 2014 Apr;63(4):375–384.

Published In

J Cardiovasc Pharmacol

DOI

EISSN

1533-4023

Publication Date

April 2014

Volume

63

Issue

4

Start / End Page

375 / 384

Location

United States

Related Subject Headings

  • Vasodilator Agents
  • Perioperative Care
  • Hypertension, Pulmonary
  • Humans
  • Cardiovascular System & Hematology
  • 3214 Pharmacology and pharmaceutical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology